Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avadel AVDL -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (180)	9/5/2007 4:27:27 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 240

Tom, This news isn't going to help the situation......... Sept 5 (Reuters) - Caraco Pharmaceutical Laboratories Ltd (CPD.A: Quote, Profile, Research) said the U.S. Food and Drug Administration has granted approval to market the company's generic version of GlaxoSmithKline's (GSK.L: Quote, Profile, Research) blood pressure drug Coreg. The approval is for the company's generic Carvedilol Tablets, of 3.125 mg, 6.25 mg, 12.5 mg and 25 mg versions, Caraco company said in a statement